Archives
-
ARCA EGFP mRNA for Transfection Controls
2026-09-13
ARCA EGFP mRNA provides a direct fluorescence readout for comparing delivery conditions, cell types, and lipid-based formulations without waiting for an indirect reporter cascade. This guide translates its cap-and-tail design into practical workflows for mammalian cell gene expression studies, including pathway experiments inspired by periostin regulation in HER2-positive breast cancer models.
-
CTOP as a Circuit-Validation Tool in Pain Research
2026-09-12
CTOP is a selective μ-opioid receptor antagonist for testing whether opioid-dependent signaling is necessary at defined points in pain circuits. This guide translates recent brain-to-spinal findings into practical assay logic, controls, and interpretation strategies.
-
From ARCA mRNA to Immune Architecture
2026-09-11
Spleen-targeted neoantigen vaccination shows how mRNA chemistry, delivery biology, and immune-cell organization must be engineered together. This thought-leadership guide translates those findings into practical synthesis, validation, and development strategies using ARCA-capped, polyadenylated mRNA.
-
Carboxylesterase and Mitochondrial H2O2 Assays
2026-09-11
The reference study shows that carboxylesterase can convert Amplex Red to resorufin without hydrogen peroxide, horseradish peroxidase, or oxygen, creating a major confounder in mitochondrial ROS measurements. Its controls and proposed corrections provide a practical framework for distinguishing genuine H2O2 release from matrix-driven probe conversion.
-
EZ Cap™ Cy5 EGFP mRNA: Dual Tracking
2026-09-10
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA reporter that separates cellular delivery from functional protein expression. Its Cap1 structure, modified uridine chemistry, and dual fluorescence support controlled mRNA delivery and translation efficiency assays.
-
Axon Trafficking Limits TIA1 Aggregation
2026-09-10
This bioRxiv preprint identifies Annexin A7 (ANXA7) as an adaptor that connects TIA1-containing ribonucleoprotein complexes to cytoplasmic dynein for retrograde axonal transport. The study proposes that persistent calcium elevation or ANXA7 loss uncouples this pathway, allowing pathological TIA1 aggregation and contributing to axonopathy and neurodegeneration.
-
Docetaxel Workflow for Cancer Research
2026-09-09
Build more reproducible Docetaxel experiments by pairing concentration-controlled cytotoxicity assays with mechanistic cell-cycle and apoptosis readouts. This workflow also shows how the palonosetron literature can improve translational interpretation without confusing antiemetic outcomes with tumor-cell killing.
-
Erlotinib Workflows for EGFR Signaling Research
2026-09-09
Erlotinib, also known as NSC 718781, provides a reversible way to connect EGFR kinase activity with proliferation, apoptosis, and therapy-resistance phenotypes. This practical guide combines biochemical and cell-based workflows with SCUBE3-focused assay design, dosing controls, and troubleshooting strategies.
-
ARCA capped mRNA synthesis kit | HyperScribe™
2026-09-08
A scenario-driven guide to reducing upstream mRNA variability in cell viability, proliferation, cytotoxicity, and translation workflows. It explains how HyperScribe™ Co-transcription mRNA Synthesis Kit Plus (ARCA, T7), SKU K1406, supports capped, polyadenylated mRNA production while keeping assay interpretation scientifically grounded.
-
CKI 7 Dihydrochloride in Translational Oncology
2026-09-08
A thought-leadership analysis of CKI 7 dihydrochloride as a mechanistic Casein kinase 1 inhibitor for connecting CK1 biology with Wnt signaling, circadian regulation, apoptosis studies, and translational cancer research—while maintaining clear boundaries around what the MAPK10/KRT16 evidence does and does not establish.
-
Self-Activatable Nanozymes for CRC Immunotherapy
2026-09-07
This ACS Nano study develops AS@PMFM, a macrophage-targeted polymeric nanozyme that uses intracellular hydrogen peroxide to generate antibacterial reactive oxygen species and eliminate Fusobacterium nucleatum reservoirs in colorectal tumors. By coupling bacterial clearance with macrophage remodeling, the platform substantially improves the rationale for combining tumor-associated bacterial control with CD47 blockade.
-
Ordered DNA Frameworks for Enzymatic DNA Synthesis
2026-09-07
The reference study introduces tetrahedral DNA nanostructures as an ordered interface for improving primer presentation during enzymatic oligonucleotide synthesis. By increasing enzyme accessibility and reducing deletion errors, the framework enabled a 60-nucleotide information-storage sequence with a reported stepwise yield of 96.82%, suggesting a practical route toward more reliable DNA synthesis.
-
Rhodamine 123: Practical Transport Assay Workflows
2026-09-05
Rhodamine 123 (chloride) enables live-cell measurement of transporter-dependent dye accumulation and efflux, making it useful for ABCB1/MDR1 studies, inhibitor screening, and multidrug-resistance workflows. This guide translates the reference study’s transporter-inhibition strategy into practical assay design while clearly separating P-glycoprotein readouts from ABCG2-specific conclusions.
-
LNP Surface Charge and V-ATPase Drive RNA Delivery
2026-09-04
A 2026 study identifies target-cell V-ATPase activity as a functional partner to LNP surface charge, showing that delivery depends on both nanoparticle properties and endo/lysosomal state. The work links this interaction to cell-state-dependent transfection, liver versus lung tropism, reticuloendothelial-system conditioning, and protein-corona composition.
-
Targeted EPO mRNA Nanoparticles for Spinal Cord Repair
2026-09-04
A 2026 study developed mannose-modified lipid nanoparticles to deliver EPO mRNA to CD206-enriched inflammatory macrophages and microglia in injured spinal cord tissue. In mice, this localized strategy reduced neuroinflammation and ferroptosis-associated damage while improving neuronal preservation, serotonergic axon integrity, and motor recovery.